v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net income (loss) $ (13,558,223) $ 897,385
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest earned on funds held in trust account (1,212,390)
Loss on initial recognition of forward purchase agreement 8,603,256  
Change in fair value of forward purchase agreement liability 1,074,131
Changes in operating assets and liabilities:    
Deferred offering cost (20,939)
Accounts payable 4,384,186 (21,716)
Prepaid expenses 44,928 (148,912)
Tax liability 264,099 294,474
Interest expense 6,671
Net cash provided by (used in) operating activities (400,013) 1,006,963
Cash flows from investing activities    
Investment into trust account (81,628,583)
Net cash used in investing activities (81,628,583)
Cash flows from financing activities    
Proceeds from promissory note 417,000
Repayment of promissory note (548,671)
Proceeds from sale of 8,000,000 units at $10 per unit in IPO net of offering cost paid at closing 78,641,719
Proceeds from sale of 248,300 units to Sponsor in private placement 2,483,000
Proceeds from sale of 40,000 units to underwriters in private placement 100
Proceeds from sale of 1,000,000 $15 strike warrants in private placement 100,000
Net cash provided by financing activities 81,093,148
Net increase in cash (400,013) 471,528
Cash at beginning of period 486,900 46,285
Cash and cash equivalents at end of period $ 86,887 $ 517,813